Skip to content

Clinical trials

Phase 3 Delayed Graft Function trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Delayed Graft Function Phase: Phase 3 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20111
20162
20181
20191
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status4
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.1
Angion Biomedica Corp1
Apellis Pharmaceuticals, Inc.1
Assistance Publique - Hôpitaux de Paris1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Institut d'Anesthesiologie des Alpes Maritimes1
Quark Pharmaceuticals1
Radboud University Medical Center1
Shahid Beheshti University of Medical Sciences1
The University of Queensland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Delayed Graft Function12
Acute Kidney Injury2
Kidney Failure, Chronic2
Reperfusion Injury2
Brain Death1
Kidney Cortex Necrosis1
Kidney Diseases1
Liver Diseases1
Pancreatic Diseases1
Renal Insufficiency, Chronic1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.